ANSNF yields 4444.44% · PFE yields 6.13%● Live data
📍 ANSNF pulled ahead of the other in Year 1
Combined, ANSNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ANSNF + PFE for your $10,000?
Anson Resources Limited engages in the acquisition, exploration, and development of mineral resources in the United States and Western Australia. The company offers lithium, bromine, caustic soda, boron, and iodine; and zinc, lead, silver, graphite, nickel-cobalt laterite, vanadium, and uranium deposits. Its flagship property is the Paradox Basin Brine project, which covers an area of 95 square kilometers located in the Utah, the United States of America. The company also holds an interest in the base metal projects comprising The Bull project, which covers an area of 82 square kilometers; Ajana/Mary Springs project that covers an area of 222 square kilometers; and Hooley Well project, which covers an area of 154 square kilometers located in Yilgarn Craton, Western Australia. In addition, it holds an interest in the Yellow Cat project that comprises 85 Lode claim, which covers an area of 708 hectares located in Thompson District, Grand County, Utah. The company was formerly known as Mayan Iron Corporation Limited and changed its name to Anson Resources Limited in January 2016. Anson Resources Limited was incorporated in 2009 and is based in West Perth, Australia.
Full ANSNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.